Skip to main content
SpringerLink
Log in

Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study"

  • Correspondence
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ramos-Fresnedo A, Pullen MW, Perez-Vega C et al (2022) The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. J Neurooncol. https://doi.org/10.1007/s11060-022-03960-6

    Article  PubMed  Google Scholar 

  2. Louis DN (2022) Glioblastoma, IDH-wildtype in: WHO classification of tumors: central nervous system tumors. International Agency for Research on Cancer (IARC). https://tumourclassification.iarc.who.int/chaptercontent/45/7. Accessed 4 March 2022.

  3. Brat DJ, Aldape K, Colman H et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for “diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV.” Acta Neuropathol 136:805–810. https://doi.org/10.1007/s00401-018-1913-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical University—Varna “Prof. Dr. Paraskev Stoyanov”, Varna, Bulgaria

    George S. Stoyanov

Authors
  1. George S. Stoyanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GS—conceptualized and wrothe the draft

Corresponding author

Correspondence to George S. Stoyanov.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stoyanov, G.S. Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study". J Neurooncol 157, 573–574 (2022). https://doi.org/10.1007/s11060-022-04000-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-022-04000-z

Search

Navigation